Gut Liver.
2017 Nov;11(6):745-746. 10.5009/gnl17408.
Estimation of Direct Medical Costs Related to Chronic Hepatitis C: A Rationale for Early Antiviral Therapy
- Affiliations
-
- 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. dyk1025@yuhs.ac
- KMID: 2395378
- DOI: http://doi.org/10.5009/gnl17408
Abstract
- No abstract available.
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Treatment of chronic hepatitis C
- Hepatitis C Virus and Antiviral Drug Resistance
- New antiviral agents for treatment of chronic hepatitis B
- Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data
- Treatment of Chronic Hepatitis C Patients Who Do Not Respond to Direct Acting Antivirals
